Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools ACC

ACC

Programs, trials, and reported response and survival for adenoid cystic carcinoma.

Data as of 11.07.2026

All studies

Axitinib (off Label)

Axitinib vs observation (randomized Phase 2)

Pfizer · Phase 2 · Completed · Enrollment 60

NCT02859012

ArmReported safety
Axitinib 5 mg twice dailyn/r
Observationn/r

A count stays a count. This page does not turn a count into a percent.